keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Agenda for Day 1 - Monday October 5th, 2026
keyboard_arrow_leftSearch & Filter
close
Streams
Formats
Agenda for Day 1 - Monday October 5th, 2026
close
Streams
Formats
Showing 2 of 2 Streams
Workshop B: Tactical Calculations and Strategy 201
Workshop C: State Drug Price Transparency & Reporting
10:45am - 11:30am
Fair Market Value: Turning Compliance into Opportunity
Regulatory updates from OIG, IRS, and DOJ on FMV
Best practices for documentation, governance, and rate-setting
Solutions for data inconsistencies, ownership challenges, and evolving models
Technology’s role in transparency, workflows, and audit readiness
Insights on centralizing FMV data and optimizing processes to reduce risk and enhance value
- Meena Datta - Partner, Sidley Austin LLP
- Trevor Wear - Partner, Sidley Austin LLP
11:35am - 12:15pm
Case Study — Product Price Increase SPTR Practical Walkthrough
- Amina Khan - US State Price Transparency & Healthcare Strategy Director, BMS
Showing 1 of 1 Streams
Workshop F: Commercialization for Emerging Pharma
1:20pm - 2:05pm
Essential Agreements and Timelines for New Pharmaceutical Companies Preparing for Successful Drug
Operational considerations for new pharmaceutical companies
Break down the key agreements required for entry into programs like MDRP, 340B, VA FSS, and Medicare Part D
How to leverage technology to meet ongoing regulatory reporting requirements
Strategies for launching new drugs
Develop multi-channel market access strategies
- Erin Mistry - Payee Strategy Government Affairs Senior Vice President, CorMedix
- Lauren Nelson - Head of Market Access and Trade, Tris Pharma
Filter
Streams
Formats
